176 related articles for article (PubMed ID: 4514336)
1. Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).
Holmsen R; Kvan L; Presthus J; Thoresen GB
Acta Neurol Scand Suppl; 1972; 51():121-2. PubMed ID: 4514336
[No Abstract] [Full Text] [Related]
2. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
Dupont E; Hansen E; Melsens S; Parkenberg H; Holm P
Acta Neurol Scand Suppl; 1972; 51():115-7. PubMed ID: 4514334
[No Abstract] [Full Text] [Related]
3. Treatment of Parkinsonism with L-dopa and decarboxylase inhibitors. An electrophysiological study.
Dietrichson P
Acta Neurol Scand Suppl; 1972; 51():111-3. PubMed ID: 4514333
[No Abstract] [Full Text] [Related]
4. [Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].
Barbeau A; Gillo-Joffroy L; Mars H; Arsenault A
Rev Can Biol; 1972; 31():Suppl:169-74. PubMed ID: 5052323
[No Abstract] [Full Text] [Related]
5. Dopa-decarboxylase inhibitors.
Lancet; 1973 May; 1(7810):979-80. PubMed ID: 4121597
[No Abstract] [Full Text] [Related]
6. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Miller EM; Wiener L
Neurology; 1974 May; 24(5):482-6. PubMed ID: 4857107
[No Abstract] [Full Text] [Related]
7. [Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism].
Dietrichson P
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2113-5. PubMed ID: 4590070
[No Abstract] [Full Text] [Related]
8. Levodopa and pressor amine sensitivity in parkinsonism.
Reid JL; Calne DB; George CF; Vakil SD
Clin Pharmacol Ther; 1972; 13(3):400-6. PubMed ID: 5026378
[No Abstract] [Full Text] [Related]
9. [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
Christiani K; Möller WD
Munch Med Wochenschr; 1973 Apr; 115(16):711-3. PubMed ID: 4197759
[No Abstract] [Full Text] [Related]
10. Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.
Pekkarinen A; Rinne UK; Salokangas R; Siirtola T; Sonninen V
Acta Neurol Scand Suppl; 1972; 51():129-30. PubMed ID: 4514339
[No Abstract] [Full Text] [Related]
11. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Streifler M; Vardi J; Kesten M
Harefuah; 1972 Nov; 83(9):362-4. PubMed ID: 4669737
[No Abstract] [Full Text] [Related]
12. [Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
Lombardo L; de la Garza R; Ivan-Reynoso G
Arch Invest Med (Mex); 1974; 5(2):105-16. PubMed ID: 4433198
[No Abstract] [Full Text] [Related]
13. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
Gattringer B; Steinhäusl H
Wien Med Wochenschr; 1972 Jun; 122(25):369-71. PubMed ID: 4558132
[No Abstract] [Full Text] [Related]
14. L-dopa level in plasma, primary condition for the kinetic effect.
Birkmayer W; Danielcyk W; Neumayer E; Riederer P
J Neural Transm; 1973; 34(2):133-43. PubMed ID: 4722571
[No Abstract] [Full Text] [Related]
15. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Birkmayer W; Linauer W; Mentasti M; Riederer P
Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492
[No Abstract] [Full Text] [Related]
16. [L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].
Fujimori N; Kito S; Yamamoto M; Itoga E; Kosaka K
Nihon Rinsho; 1974 Mar; 32(3):579-86. PubMed ID: 4859014
[No Abstract] [Full Text] [Related]
17. Treatment of Parkinson's disease with L-DOPA and an association L-DOPA plus a DOPA decarboxylase inhibitor.
Fazio C; Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Volante F
Z Neurol; 1972; 202(4):347-55. PubMed ID: 4117654
[No Abstract] [Full Text] [Related]
18. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Stammler A; Vielhaber K
Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521
[No Abstract] [Full Text] [Related]
19. [Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
De Divitiis E; Cerillo A; Tata MR; Decina A
Acta Neurol (Napoli); 1973; 28(2):208-12. PubMed ID: 4709076
[No Abstract] [Full Text] [Related]
20. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
